financetom
Business
financetom
/
Business
/
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization
Apr 8, 2024 11:20 AM

01:46 PM EDT, 04/08/2024 (MT Newswires) -- CorMedix ( CRMD ) said Monday it entered a five-year agreement to supply its DefenCath product to Florida-based dialysis organization ARC Dialysis.

DefenCath was approved in the US in November 2023 and CorMedix ( CRMD ) plans to commercialize the product in the inpatient setting starting April 15.

Price: 4.73, Change: +0.02, Percent Change: +0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved